Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Pharmacokinetics of buprenorphine: a comparison of sublingual tablet versus liquid after chronic dosing.

Compton P, Ling W, Chiang CN, Moody DE, Huber A, Ling D, Charuvastra C.

J Addict Med. 2007 Jun;1(2):88-95. doi: 10.1097/ADM.0b013e31806dcc3e.

PMID:
21768940
2.

Pharmacokinetics of the combination tablet of buprenorphine and naloxone.

Chiang CN, Hawks RL.

Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S39-47. Review.

PMID:
12738349
3.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
4.

Buprenorphine: how to use it right.

Johnson RE, Strain EC, Amass L.

Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S59-77. Review.

PMID:
12738351
5.

Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.

Maremmani I, Gerra G.

Am J Addict. 2010 Nov-Dec;19(6):557-68. doi: 10.1111/j.1521-0391.2010.00086.x. Epub 2010 Sep 21. Review.

PMID:
20958853
6.
7.

Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain.

Plosker GL.

Drugs. 2011 Dec 24;71(18):2491-509. doi: 10.2165/11208250-000000000-00000. Review.

PMID:
22141389
8.

Opioid dependence treatment, including buprenorphine/naloxone.

Raisch DW, Fye CL, Boardman KD, Sather MR.

Ann Pharmacother. 2002 Feb;36(2):312-21. Review.

PMID:
11847954
9.

Selective review and commentary on emerging pharmacotherapies for opioid addiction.

Ling W, Mooney L, Zhao M, Nielsen S, Torrington M, Miotto K.

Subst Abuse Rehabil. 2011 Oct 28;2:181-8. doi: 10.2147/SAR.S22782. eCollection 2011. Review.

Items per page

Supplemental Content

Write to the Help Desk